Morepen Laboratories (MOREPENLAB) | Stock Overview & Key Data
Morepen Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹48.55
High: ₹49.46
on October 6, 2025
52 Week Range
Low: ₹42.00
High: ₹94.45
on April 7, 2025
on October 17, 2024
All-Time High: ₹175.00 on October 11, 1999
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR26.7B
EPS
1.69
P/E Ratio (TTM)
28.83
Forward P/E
N/A
P/B Ratio
2.45
PEG Ratio
-0.40
Div. Yield
0.43%
ROE
9.94%
Beta
0.699
Debt to Equity
8.85
Financial Highlights
Profitability
Gross Margin
38.30%
Operating Margin
4.55%
Profit Margin
5.14%
Returns and Earnings
Return on Assets (TTM)
6.64%
Return on Equity (TTM)
9.94%
EBITDA
INR1.7B
Net Income (TTM)
INR926.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR32.87
Quarterly Revenue Growth (YoY)
-6.30%
Quarterly Earnings Growth (YoY)
-70.30%
Dividend Information
Last 12-Month Dividend
₹0.20
Current Dividend Yield
0.43%
3-Year Average Dividend Yield
0.43%
3-Year Average Annual Dividend
₹0.07
3-Year Total Dividends
₹0.20
Ex-Dividend Date
August 29, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Morepen Laboratories MOREPENLAB | 26.73B Small-cap | 1.37% | -0.73% | -23.63% | 2.01% | -38.46% | -44.35% | 76.88% | 76.56% |
| Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 4.12% | 4.66% | -1.50% | -0.70% | -12.45% | -13.00% | 69.49% | 239.84% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | 2.26% | -3.33% | -15.42% | 10.79% | -4.06% | -5.14% | 63.08% | 80.80% |
| Innova Captab INNOVACAP | 48.64B Small-cap | 0.46% | -4.62% | -2.11% | -0.23% | -24.99% | 16.46% | 53.72% | 53.72% |
| Suven Life Sciences SUVEN | 47.99B Small-cap | 3.79% | -10.27% | -21.82% | 76.25% | 63.70% | 49.21% | 215.69% | 329.98% |
| Gujarat Themis GUJTHEM | 46.19B Small-cap | 5.81% | 11.73% | 24.24% | 72.58% | 76.09% | 95.83% | 95.83% | 95.83% |
Ownership & Short Interest
Insider Ownership
42.69%
Institutional Ownership
1.38%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2M
Average 90-Day Volume
3M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MOREPENLAB's 52-week high and low?
- In the last 52 weeks, Morepen Laboratories reached a high of ₹94.45 (on October 17, 2024) and a low of ₹42.00 (on April 7, 2025).
- What is the market cap and P/E ratio for MOREPENLAB?
- Curious about Morepen Laboratories's size and valuation? Its market capitalization stands at 26.73B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.83, and the forward P/E (looking ahead) is N/A.
- Does MOREPENLAB pay dividends? If so, what's the yield?
- Yes, Morepen Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.43%, and the company has paid an average of ₹0.07 per share annually over the past 3 years.
- Who are Morepen Laboratories's main competitors or similar companies to consider before investing?
When looking at Morepen Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -13.00% 69.49% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic -5.14% 63.08% Innova Captab
INNOVACAP48.64B Healthcare Drug Manufacturers - Specialty & Generic 16.46% 53.72% Suven Life Sciences
SUVEN47.99B Healthcare Drug Manufacturers - Specialty & Generic 49.21% 215.69% Gujarat Themis
GUJTHEM46.19B Healthcare Drug Manufacturers - Specialty & Generic 95.83% 95.83% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Morepen Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Morepen Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.94%, the Debt to Equity ratio from the most recent quarter is 8.85, and its Gross Profit Margin stands at 38.30%.
- What is the recent revenue and earnings growth for MOREPENLAB?
- Looking at Morepen Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR18B. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.30%, and quarterly earnings saw a YoY growth of -70.30%.
- How much of MOREPENLAB stock is held by insiders and institutions?
- Wondering who owns Morepen Laboratories stock? Company insiders (like executives and directors) hold about 42.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.38%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.